BPC-157 + TB-500 10mg Blend
Components: BPC-157 + TB-500
A balanced 50/50 recovery blend combining BPC-157 and TB-500 in a 10mg vial. Targets tissue repair, angiogenesis, and cell migration through complementary healing pathways.
Blend Composition
This is a single pre-mixed vial — one reconstitution for all components.
Synergy Explanation
BPC-157 promotes angiogenesis, upregulates growth factor receptors, and provides localized tissue repair through the nitric oxide pathway. TB-500 (Thymosin Beta-4 fragment) drives systemic cell migration and differentiation via actin regulation. Together they address overlapping but distinct phases of musculoskeletal repair — BPC-157 anchors local healing while TB-500 recruits circulating repair cells.
Reconstitution Guide
-
Allow the vial to reach room temperature for 5 minutes before handling.
-
Draw 3.0 mL of bacteriostatic water into a sterile syringe.
-
Sterilize the vial stopper with an alcohol swab and allow to dry.
-
Inject the BAC water slowly down the inside wall of the vial u2014 do not aim the stream directly onto the powder.
-
Gently swirl or roll the vial until the powder is fully dissolved. Do not shake.
-
Label with reconstitution date and store refrigerated at 2u20138 u00b0C (35.6u201346.4 u00b0F).
Always use bacteriostatic water — not sterile water — to extend shelf life of your reconstituted blend.
Dosage Protocols
| Protocol | Dose | Frequency | Duration | Route | Notes |
|---|---|---|---|---|---|
| Standard Recovery Protocol | 600u20131000 mcg once daily | Once daily | 8u201312 weeks | SubQ | Administer subcutaneously near the injury site or in the abdomen. Typical starting dose is 750 mcg once daily. |
Storage Instructions
Lyophilized (Dry)
Store at ≤−15 °C (5 °F). For long-term storage, ≤−50 °C (−58 °F) preferred.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F). Use within 3–4 weeks. Do not freeze after reconstitution.
Keep the reconstituted vial refrigerated at all times. Protect from light.
Supplies Needed
-
Bacteriostatic water (BAC water) 10 mL vial
-
Insulin syringes (U-100) 0.5 mL, 29u201331 gauge
-
Alcohol swabs For stopper and injection site sterilization
-
Reconstitution syringe 3 mL with 23g needle for adding BAC water
Potential Side Effects
Generally well tolerated at research doses. Possible mild injection site reactions. Some individuals report temporary fatigue in the first week.
Questions about BPC-157 + TB-500 10mg Blend
At a 50/50 ratio, each 750 mcg dose contains 375 mcg BPC-157 and 375 mcg TB-500.
At 750 mcg once daily, one vial provides approximately 13 doses u2014 roughly 2 weeks per vial.
Subcutaneous injection near the injury is a common research approach. Abdominal injection also works due to the systemic distribution of both peptides.
Research Use Disclaimer
This content is for educational purposes only and does not constitute medical advice. For research use only.